# A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling

> **NCT05948085** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zavegepant 10 mg IN

## Key facts

- **NCT ID:** NCT05948085
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-10
- **Primary completion:** 2023-09-05
- **Final completion:** 2023-09-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05948085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05948085, "A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05948085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*